MMIRF

Healthcare Biotechnology

MedMira Inc.

$0.04

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

27.93M

Avg Volume

2,338

52W High

$0.95

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-1.59

P/S Ratio

75.37

Margins

Gross Margin (130.9%)

Operating Margin (109.8%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

308.0%

Return on Assets

(34.3%)

Liquidity & Leverage

Current Ratio

0.06

Quick Ratio

0.05

Total Debt

17.42M

About

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

medmira.com